Dr. Andy

Reflections on medicine and biology among other things

Wednesday, April 06, 2005

The Economic Impact of Avian Flu

is discussed here.

CLSA Asia-Pacific Markets, the Asian investment banking arm of Crédit Agricole of France, estimated in a report on Monday that the disease had already cost Asian nations $8 billion to $12 billion, mostly from the deaths or destruction of 140 million chickens and other poultry. But the cost would be greater if the disease gained the ability to spread easily from person to person, a possibility that is not factored into current stock and other asset prices, said Christopher Wood, CLSA's chief equity strategist.
"the cost would be greater" may qualify as understatement of the year.

While I don't think this will be as bad in the US as some are predicting, it could be bad in Asia where there is less capacity for sophisticated medical care. Or it might just die out with a couple hundered human cases.

1 Comments:

At 10:06 AM, Blogger Unknown said...

For us novices, can you explain why they can't put this strain into next year's flu vaccine? I read in the NYT that it will take several years to develop an immunization.

 

Post a Comment

<< Home